The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis-Reference-Cited by-同舟云学术

The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis

Published:2020-04-20 Issue:2 Volume:39 Page:365-376
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Knijnik Pedro Glusman,Brum Pietro Waltrick,Cachoeira Eduardo Tosetto,Paludo Artur de Oliveira,Gorgen Antônio Rebello Horta,Burttet Lucas Medeiros,Neyeloff Jeruza Lavanholi,Neto Brasil Silva

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-020-03202-2.pdf

Reference33 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

2. Thomas LN, Lazier CB, Gupta R et al (2005) Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate 63:231–239

3. Azzouni F, Godoy A, Li Y, Mohler J (2012) The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol 2012:530121

4. Gormley GJ, Stoner E, Bruskewitz RC et al (1992) The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. New Engl J Med 327:1185–1191

5. Andriole GL, Guess HA, Epstein JI et al (1998) Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS study group. Proscar long-term efficacy and safety study. Urology 52:195–201 (discussion 201–2)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality;2024-07-08

2. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

3. 5-alpha reductase inhibitors use in prostatic disease and beyond;Translational Andrology and Urology;2023-03